Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil for Intralesional Immunotherapy of Anogenital Warts
NCT05761002Unknown
- Sponsor
- Zagazig University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of qHPV vaccine in anogenital warts, sponsored by Zagazig University. Primary endpoint: improvement of lesion at 6 months. Status: unknown.
02
Drugs
qHPV vaccine
03
Conditions
anogenital warts
Beyond the preview
Go deeper on NCT05761002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761002.